Digital transformation key to managing rising organisational healthcare costs in India
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
10+ emerging markets, Japan & ANZ transition in final phase
New facility is part of Aptar Pharma’s global expansion program
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
Currently, Venkat is Lead – Market Access, India at Pfizer
Subscribe To Our Newsletter & Stay Updated